Powder Delivery TRIZ Cases

Cyano-substituted poly(arylene vinylene) nanoparticles stabilized with biocompatible surfactants enable stable aqueous dispersions.

A pH-responsive diblock copolymer accumulates at tumor sites to enable specific fluorescence imaging under near-infrared light.

A lyophilized hepatic growth factor formulation combines trehalose and specific amino acids to stabilize the protein structure.

Apoptotic tumor cell vesicles deliver comprehensive antigen spectra to antigen-presenting cells.

Liquid nitrogen jet milling maintains sub-zero temperatures to prevent thermal degradation of heat-sensitive proteins during particle size reduction.

Salt conversion and micronization improve iniparib solubility, reducing cytotoxicity while maintaining stability.

A saccharide coating film encapsulates antitumor agents to create stable particulate preparations.

A pharmaceutical formulation solubilizes difficult HPV E6 peptides using trehalose and glycine to enhance immunogenicity.

Polynucleotide nanoparticles genetically modify T cells to express specific receptors, resolving vaccine failure in compromised immune systems.

A recombinant prokaryotic collagen with a non-thrombogenic triple helical backbone prevents postoperative adhesions without triggering an immune response.

Controlled spray drying parameters produce amorphous particles that prevent cholesterol crystallization and alkalotic pH during reconstitution.

Self-assembling peptide conjugates control particle size and impurities to improve targeted delivery efficiency and bioavailability.

Lipid embedding via spray congealing coats pimobendan particles, resolving pH-dependent solubility issues and improving veterinary bioavailability.

A capsule cavity sized to 50-95% of the capsule length rotates within swirling airflow induced by a non-parallel end cap channel.

Catheter-delivered embolic particles inhibit ghrelin production to address invasive surgery limitations.

Nanoformulations incorporate targeting ligands to increase delivery to hypoxic tumor cores and stroma, overcoming poor drug penetration.

Segmenting Vadadustat polymorphs via X-ray diffraction resolves complexity in selecting stable oral dosage forms.

Segmented barium sulfate cores capped with polymers maintain radiopacity while preventing capillary clogging during injection.

Low-temperature processing of GLP-1 agonist formulations minimizes fibril formation while maintaining therapeutic efficacy.

Pyrolysis embeds lanthanide oxides in amorphous carbon, resolving neutron radiation sensitivity and scalability issues in radiotherapy.

A dehydrated granular bone substitute composition hydrates into an injectable hydrogel for surgical use.

Nonpolar solvent washing removes unbound active compounds from the loaded resin, preventing dissociation and ensuring rapid gastric release.

Antibody-functionalized gold nanoparticles convert laser energy into localized heat to eliminate cancer cells while sparing normal bladder tissue.

An alkylene oxide derivative acts as a chemical bridge between humectants and skin tissue to enhance moisture retention.

Spatially arranged pharmaceutical particles release active agents as fluid flows through a drinking device, resolving swallowing difficulties for patients.

Hyaluronic acid conjugates deliver imidazoquinoline analogues to secondary lymphoid tissues.

Organic surfactants modify metal-organic framework surfaces to control nanoparticle size and porosity.

Modified release gamma-hydroxybutyrate formulation segments dose into immediate and sustained portions to achieve high bioavailability.

Lactobacillus paracasei LMG S-26420 overcomes low conversion yields by producing prevalent c9-t11 and t10-c12 isomers through optimized culture conditions.

Injectable spherical copolymer particles enable controlled therapeutic release through hydrolysis.

Controlled water addition contracts oil droplets to form high-sphericity cellulose derivative beads.

A glass microsphere incorporates a diffusion region containing a second nuclide to enable high radiation dose delivery and in vivo imaging capabilities.

Ascorbic acid and EDTA prevent rancidity in omega-3 fatty acid powders.

Zeolitic imidazolate framework nanoparticles reduce follicle-stimulating hormone levels to address peri-menopausal bone loss and obesity.

Polyethylene glycol linked adrenomedullin utilizes a carbamate linker to achieve slow release kinetics, eliminating the need for continuous infusion therapy.

Segmented RNA sequences encode Omicron and Delta spike proteins within lipid nanoparticles, resolving efficacy drops against emerging variants.

EMMPRIN inhibitors block the EMMPRIN-MMP-9 pathway, reducing infarct size and restoring function after ischemia/reperfusion.

Proline replaces sugar stabilizers in rHDL formulations to maintain lyophilization stability while reducing renal toxicity risks.

Intravenous Sertoli cells transport chitosan nanoparticles to the pulmonary pre-capillary vascular bed.

Reverse enteric coating on benzonatate matrices controls drug release kinetics through pH-dependent dissolution resistance.

Hydrothermal synthesis of yttrium phosphate particles using controlled pH and stoichiometric excess.

Bispecific chimeric molecules combine VEGF-binding moieties with Ang2 antagonist peptides to enhance binding affinity.

Low molecular weight polyhydric alcohols penetrate the skin barrier to activate Langerhans cells and enhance immune responses.

A prefilming atomizer forms a liquid thin film and impinges it with flowing gas to create uniform droplets.

A biodegradable core-shell nanocomposite encapsulates active ingredients to enable controlled release across the blood-brain barrier.